Identification of mitophagy‐associated proteins profile as potential plasma biomarkers of idiopathic Parkinson's disease
Open Access
- 21 November 2023
- journal article
- research article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 30 (4)
Abstract
Background: Despite extensive work to identify diagnostic plasma markers for Parkinson's disease (PD), there are still no accepted and validated surrogate biomarkers. Mitophagy‐associated proteins (MAPs), including PTEN‐induced putative kinase 1 (PINK1), Parkin, phosphoglycerate mutase 5 (PGAM5), BCL2 interacting protein 3 (BNIP3), and phosphorylated‐TBK1 (p‐TBK1), are, to our best knowledge, not well studied as a panel of biomarkers of neurodegeneration in PD.Methods: The study population comprised 116 age‐matched controls (HC), 179 PD patients, alongside and 90 PD syndromes (PDs) divided between two cohorts: (i) the modeling cohort (cohort 1), including 150 PD, 97 HC, and 80 PDs; and (ii) the validated cohort (cohort 2), including 29 PD, 19 HC, and 10 PDs.Results: MAPs are elevated in the plasma of PD patients. PINK1, Parkin, and PGAM5 displayed the top three measurable increase trends in amplitude compared to BNIP3 and p‐TBK1. Moreover, the area under the curve (AUC) values of PINK1, PGAM5, and Parkin were ranked the top three MAP candidates in diagnosis accuracy for PD from HC, but the MAPs make it hard to differentiate PD from PDs. In addition, there are higher plasma PINK1‐Parkin levels and prominent diagnostic accuracy in A‐synuclein (+) subjects than in A‐synuclein (−) subjects.Conclusions: These results uncover that plasma MAPs (PINK1, Parkin, and PGAM5) may be potentially useful diagnostic biomarkers for PD diagnosis. Studies on larger cohorts would be required to test whether elevated plasma MAP levels are related to PD risk or prognosis.Keywords
This publication has 42 references indexed in Scilit:
- Model selection and psychological theory: A discussion of the differences between the Akaike information criterion (AIC) and the Bayesian information criterion (BIC).Psychological Methods, 2012
- Phosphorylated α‐synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's diseaseThe FASEB Journal, 2011
- Cognitive impairment using education-based cutoff points for CMMSE scores in elderly Chinese people of agricultural and rural Shanghai ChinaActa Neurologica Scandinavica, 2011
- α-Synuclein impairs macroautophagy: implications for Parkinson’s diseaseJournal of Cell Biology, 2010
- Dose‐response analyses using restricted cubic spline functions in public health researchStatistics in Medicine, 2010
- Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK)Sleep Medicine, 2010
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1Science, 2004
- A Chinese version of the mini-mental state examination; Impact of illiteracy in a Shanghai dementia surveyJournal of Clinical Epidemiology, 1988
- ParkinsonismNeurology, 1967